We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Metabolon Signs Collaboration with Army Medical Research Institute

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Metabolon Signs Collaboration with Army Medical Research Institute"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Metabolon, Inc. has announced the signing of a contract supporting the US Army Medical Research Institute of Infectious Diseases (USAMRIID).

The collaboration uses Metabolon’s proprietary metabolomics platform to study the biochemical profiles of humans given the AVA anthrax vaccine. The AVA vaccine is the only FDA-licensed anthrax vaccine for humans.

“This collaboration represents the first large-scale metabolomics study of human subjects given a vaccine,” said Mike Milburn, Metabolon’s Chief Scientific Officer. “This type of comprehensive biochemical profiling will help USAMRIID better understand the vaccine’s safety, efficacy, and mechanism of action.”